
Transgene Provides Business and Financial Update for Q1 2026 … Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) – Topline data expected by the end of Q1 2028 a...
Transgene Provides Business and Financial Update for Q1 2026 … Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) – Topline data expected by the end of Q1 2028 a...